425 related articles for article (PubMed ID: 11793011)
1. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.
Costa RM; Federov NB; Kogan JH; Murphy GG; Stern J; Ohno M; Kucherlapati R; Jacks T; Silva AJ
Nature; 2002 Jan; 415(6871):526-30. PubMed ID: 11793011
[TBL] [Abstract][Full Text] [Related]
2. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.
Li W; Cui Y; Kushner SA; Brown RA; Jentsch JD; Frankland PW; Cannon TD; Silva AJ
Curr Biol; 2005 Nov; 15(21):1961-7. PubMed ID: 16271875
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for the learning and memory deficits associated with neurofibromatosis type I.
Silva AJ; Frankland PW; Marowitz Z; Friedman E; Laszlo GS; Cioffi D; Jacks T; Bourtchuladze R
Nat Genet; 1997 Mar; 15(3):281-4. PubMed ID: 9054942
[TBL] [Abstract][Full Text] [Related]
4. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
5. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of synaptic plasticity-related genes in the NF1+/- mouse hippocampus.
Park CS; Zhong L; Tang SJ
J Neurosci Res; 2009 Nov; 87(14):3107-19. PubMed ID: 19475561
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromin regulation of ERK signaling modulates GABA release and learning.
Cui Y; Costa RM; Murphy GG; Elgersma Y; Zhu Y; Gutmann DH; Parada LF; Mody I; Silva AJ
Cell; 2008 Oct; 135(3):549-60. PubMed ID: 18984165
[TBL] [Abstract][Full Text] [Related]
8. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1.
Costa RM; Yang T; Huynh DP; Pulst SM; Viskochil DH; Silva AJ; Brannan CI
Nat Genet; 2001 Apr; 27(4):399-405. PubMed ID: 11279521
[TBL] [Abstract][Full Text] [Related]
9. Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.
van der Vaart T; van Woerden GM; Elgersma Y; de Zeeuw CI; Schonewille M
Genes Brain Behav; 2011 Jun; 10(4):404-9. PubMed ID: 21352477
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
11. A mouse model for learning and memory defects associated with neurofibromatosis type I.
Silva AJ; Elgersma Y; Friedman E; Stern J; Kogan J
Pathol Biol (Paris); 1998 Nov; 46(9):697-8. PubMed ID: 9885821
[No Abstract] [Full Text] [Related]
12. Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1.
Costa RM; Silva AJ
J Child Neurol; 2002 Aug; 17(8):622-6; discussion 627-9, 646-51. PubMed ID: 12403561
[TBL] [Abstract][Full Text] [Related]
13. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
14. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.
Tong J; Hannan F; Zhu Y; Bernards A; Zhong Y
Nat Neurosci; 2002 Feb; 5(2):95-6. PubMed ID: 11788835
[TBL] [Abstract][Full Text] [Related]
16. Motor deficits and neurofibromatosis type 1 (NF1)-associated MRI impairments in a mouse model of NF1.
Robinson A; Kloog Y; Stein R; Assaf Y
NMR Biomed; 2010 Dec; 23(10):1173-80. PubMed ID: 20586111
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
19. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
Hingtgen CM; Roy SL; Clapp DW
Neuroscience; 2006; 137(2):637-45. PubMed ID: 16298082
[TBL] [Abstract][Full Text] [Related]
20. [Learning disorders in neurofibromatosis type 1].
Garcia-Penas JJ
Rev Neurol; 2017 Feb; 64(s01):S59-S63. PubMed ID: 28256688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
